Export

Meglumine antimoniate
Essential medicine status
General description
Meglumine antimoniate is a antimony derivative used to treat visceral, cutaneous and mucosal leishmaniasis.
Medicine type
Chemical agent
EML status history
First added in 1987 (TRS 770) for Visceral leishmaniasis
Therapeutic equivalent for
Recommendations
Section
Antileishmaniasis medicines
  • Parenteral > General injections > IM: 30% in 5 mL ampoule equivalent to approximately 8.1% antimony